Provectus Biopharmaceuticals Receives Notice of Allowance for Adult Solid Tumor Cancer Combination Therapy Patent for PV-10® Immunotherapy from United States Patent and Trademark Office

    NEXT STORY
    Ascendis Pharma A/S Announces Participation at the J.P. Morgan 10th Annual Napa Valley Biotech Forum
    PREV STORY
    Global Inductive Proximity Sensors Market to Reach $2.4 Billion by 2027
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Spring Bank Announces FDA Acceptance of IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors

    author_avatar
    NASDAQ Market News

    Global Wireless Health and Fitness Devices Industry

    author_avatar
    NASDAQ Market News

    Sanofi: CHMP recommends approval of Praluent® (alirocumab) to reduce cardiovascular risk in people with established atherosclerotic cardiovascular disease

    CHMP recommends approval of Praluent® (alirocumab) to reduce cardiovascular risk in people with established ...

    author_avatar
    NASDAQ Market News